Key findings
- 55 pairsof people with ME/CFS and low-active controls, matched for sex, age and baseline aerobic capacity, in the largest 2-day CPET study to date (84 ME/CFS, 71 controls)
- two weeks vs 2 daysaverage time to recover from PEM in ME/CFS, compared with healthy controls
- 1:3work-to-rest ratio the ACSM recommends for pacing, which may need to be 1:4 or 1:6 depending on illness severity
- 162 vs 130 mmHgsystolic pressure at 120 W in one patient on the first and second CPET, an example of an attenuated response
Abstract
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) encompasses seemingly varied and disparate symptoms, making the diagnosis challenging and arduous. The hallmark symptom of post exertional malaise, sometimes considered a disease within itself, erodes the pre-illness lifestyle to a very low tolerance for exertion and consequently, a substantially lower level of physical activity. However, many with ME/CFS, particularly early in the diagnosis, routinely exceed the new, lower tolerance for daily activities and further worsen the post exertional malaise response and health status. Identifying post exertional malaise requires a temporal assessment of symptom onset or exacerbation and the resultant impact on functional activities. Objective data from sequential cardiopulmonary exercise tests over two days (2-d CPET) has documented the deleterious effects of post exertional malaise and decline in exertion tolerance, oxygen consumption, and energy production in ME/CFS compared to healthy controls. These consistent CPET findings are further enriched by additional measures routinely obtained during CPET that point to mechanistic failures in energy metabolism. Additional insight and guidance for treatment and management of ME/CFS may lie in a deeper examination of routine CPET variables that consistently support dysfunction of key aspects of autonomic regulation. Understanding what we learn from a 2-d CPET is essential to providing safe guidance for physical activity and medical management of one with ME/CFS.
Introduction
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a multisystem illness characterized by substantial reductions in pre-illness levels of activity, impaired cognition, and post exertional symptom exacerbation or malaise (PEM), amongst other debilitating symptoms1. This reduction of activity compared to pre-illness levels persists at least 6 months2. The profound fatigue in ME/CFS is not alleviated by rest, with the hallmark symptom of PEM marked by exhaustion, brain fog, muscle pain, and a worsening of symptoms with even minimal physical or cognitive/mental exertion3.
While many of the symptoms considered in the diagnosis of ME/CFS may also be experienced periodically by healthy individuals and those with other medical conditions, PEM is ubiquitous in ME/CFS2,4. Studies to characterize PEM found that individuals may experience a wide range of symptoms including, but not limited to: fatigue, brain fog, headaches, sleep disturbances, muscle pain, and flu-like symptoms3,5. Unfortunately, PEM can be triggered in ME/CFS by both physical and cognitive exertion, with even the most basic of activities of daily living provoking symptoms. Further, recovery from exertion may occur on a delayed timeline5–12. A study by Holtzman et al.5 surveyed patients regarding their PEM experience and reported highly variable symptoms, onset of symptom exacerbation, and impact of type, intensity, frequency, and length of exertion on the duration of PEM symptoms. Across studies, activities of daily living (ADL) resulted in a similar provocation and timeline of PEM symptoms as that of maximal exercise3,6,12. That is, even regular physical/cognitive exertion and/or emotional distress experienced in daily life triggered PEM symptoms. Furthermore, the events resulted in symptom onset anywhere from immediately to >24 hours after the event6, and exacerbation that lasted anywhere from 1 hour to 1+ years post-trigger, with a majority of subjects reporting their duration of PEM ranges from 1–7 days. The following provides context to more fully understand the impact of the PEM experience for one with ME/CFS, and the most recent recommendations for activity and exercise threshold to minimize the risk of PEM. Further, objective data, in addition to oxygen consumption, that is routinely obtained during cardiopulmonary exercise tests is discussed to more fully characterize potential mechanisms that underlie the deleterious impact of ME/CFS on functional capacity.
The Post Exertional Malaise Experience
Through focus group work with ME/CFS patients, Stussman et al.3 categorized daily events that triggered PEM within the cognitive, emotional, and physical domains. The cognitive domain included activities such as reading a book, listening to music, driving, and grocery shopping; the physical domain included walking, vacation, or attending a concert or doctor’s appointment; and the emotional domain included dealing with other’s feelings and family events. Interestingly, attending doctor’s appointments (a regular and frequent event for many with ME/CFS), contributed as a cognitive, physical, and emotional trigger for many of those surveyed. Importantly, this study also asked participants to compare their daily PEM symptoms to that provoked by completion of their cardiopulmonary exercise test (CPET). Similar symptoms were reported for daily PEM and CPET-induced PEM, with the most overlap in magnitude and severity of exhaustion, cognitive difficulties, and neuromuscular complaints. These subjective survey data are in line with objective data from studies of protracted recovery for ME/CFS following CPETs in contrast to inactive, healthy counterparts8,9,11,13,14. Similarly, the timeline of recovery from PEM was delayed in ME/CFS, requiring an average of two weeks to recover compared to 2 days for healthy controls15.
The work of Stussman et al.3 highlighted the level of sensitivity of many with ME/CFS regarding the complexity and temporal characteristics of their individual PEM experience. Subsequent studies sought to characterize daily activity levels of people with ME/CFS16–22, and indicate that those with ME/CFS are much less active than their healthy counterparts. Using continuous accelerometry to assess physical activity level, Receno et. al.23 reported that people with ME/CFS spent significantly more daytime hours in sedentary behaviors and less time in light, moderate, or vigorous-level activities compared to healthy, sedentary controls. These patterns persisted even when a full day was split into daytime and nighttime components. Similarly, these activity patterns were also evident both before and after a 2-day CPET protocol. The findings indicate that people with ME/CFS 1) limit daily activity to avoid PEM and 2) take longer to recover from fatiguing exercise. Importantly, while recovery did take longer compared to healthy controls, those with ME/CFS returned to their ‘normal’ activity patterns within 10 days post CPETs suggesting a persistence to exert beyond levels that provoke PEM simply to ‘live life’.
Oxygen consumption and hemodynamic data from CPET provides useful metrics to guide physical activity to reduce the risk of PEM. Oxygen consumption is an indirect measure of energy production and can be expressed as metabolic equivalent of task (MET), where 1 MET=3.5 ml·kg-1·min-1. One MET is an estimate of the average resting energy expenditure. It allows for a direct comparison with published MET values for a range of physical activities including occupational, sports, ADLs, and more24. Comparing a patient’s peak and ventilatory/anaerobic threshold (VAT) level of oxygen consumption to published MET value activities provides a context for the types and levels of activities that fall within the energy ‘envelope’ of a patient’s exertional tolerance. Conversely, types of activities that are at or exceed the energy producing capacity are to be avoided to minimize the risk of PEM. For many with ME/CFS, household chores such as cleaning, washing dishes, cooking, or self-care activities such as dressing/undressing, can require an intensity of effort at or above one’s VAT level of energy production and provoke PEM. Walking (3.0 METs) for up to a total of two hours during a workday, as is expected of sedentary level work in the U.S., may exceed the VAT for many with ME/CFS. Likewise, with ME/CFS, activities such as climbing stairs, playing with children, or grocery shopping could require maximal effort comparable to that of a CPET. These examples are consistent with the focus group sentiments reported in Stussman et. al.3. As with recovery following CPET, recovery back to ‘baseline’ following daily activities that require maximal effort for one with ME/CFS could take an average of 2 weeks15.
For ME/CFS, moderating daily physical activity level to below an intensity that exacerbates PEM, known as ‘pacing’, has merit based on physiologic findings. Findings from 2-d CPET and other studies reveal metabolic abnormalities and reduced mitochondrial energy production25–27, lowering the threshold of oxidative metabolism and work output. Compared to healthy controls, ME/CFS show significantly reduced oxygen consumption at peak (VO2peak) and anaerobic threshold (VO2VAT)9,14,28–30. Moreover, during a second CPET 24 hours later to assess for normal recovery, VO2peak and VO2VAT in ME/CFS declined. This phenomena was not seen in sedentary controls, and further signals impaired recovery8,9,14,28. Overall, results of CPET 1 demonstrate comparatively lower oxygen consumption and energy production in ME/CFS, while CPET 2 indicates protracted recovery as evidence of PEM31.
The American College of Sports Medicine32 provides evidence-based exercise guidelines for healthy and special populations based on the ‘FITT’ principle (frequency, intensity, time, type). Graded exercise therapy (GET) is based on the FITT principle and is an effective and systematic approach to improving overall fitness and aerobic capacity for most individuals, both healthy and with various diseases33–35. It is effective because primary adaptations to exercise ‘stress’ occur during the recovery phase following exercise. Since recovery is protracted and symptomatic with ME/CFS, normally predictable adaptation fails to occur and, instead, GET worsens the overall health status36. Consequently, the GET approach to exercise will provoke PEM because 1) it will exceed the very low ‘safe’ aerobic threshold of energy metabolism and 2) it does not accommodate the protracted and variable duration of recovery required by those with ME/CFS15,37,38.
Unlike many other diseases in which exercise intensity is based on a percentage of heart rate reserve, the ACSM guidelines for ME/CFS share a common tenet which is guided by the provocation or absence of PEM. That is, FITT parameters are guided by the practitioner’s risk-to-benefit assessment and always revised based on whether PEM is provoked following an exercise session. For most, this approach to daily life is a significant departure from the pre-ME/CFS lifestyle but is critical to reduce the risk of PEM. Recent reviews of exercise studies indicate that carefully curated exercise, not GET, significantly improves fatigue, sleep, quality of life, and depression in ME/CFS patients. Significant improvements in cardiopulmonary capacity (VO2peak) are not to be expected, but tolerance for low-level activities in which individual energy limits are strictly respected, can be an effective strategy for symptom management39,40.
A Cardiopulmonary Exercise Test Yields More Than Oxygen Consumption Data
In addition to VO2 at peak and ventilatory/anaerobic threshold (VO2@VAT), 2-d CPET results for persons with ME/CFS provide considerable additional meaningful and instructive data to inform diagnosis and treatment approaches8. However, interpreting 2-d CPET data requires a robust understanding of the ‘normal’ responses of cardiac, pulmonary, metabolic, and hemodynamic variables to incremental exercise1,32,41, normal test-retest variability of these measures42–46, as well as comparison with age/sex predicted values8,47,48. Clinical assessment via a single CPET has long been used to classify disease status and severity based on CPET measures during graded exercise49. Consecutive day CPETs for ME/CFS reveal the core pattern of responses to incremental exercise. Changes from test 1 to test 2, not afforded by a single CPET, implicate autonomic dysregulation8,50,51 postulated to contribute to dysfunctional energy metabolism8,9,14,51–54.
The largest 2-day CPET study of ME/CFS to date included 84 ME/CFS and 71 healthy, low-active controls (CTL). Using a subset of the cohort, 55 pairs of ME/CFS and CTL were matched for sex, age, and baseline aerobic capacity (VO2peak from test 1), effectively minimizing the impact of these variables on CPET outcome measures8. Table 1 includes results excerpted largely from Keller et al.8 as well as some other sources55,56 of 2-d CPET findings in ME/CFS. The table includes CPET variables that differed significantly between ME/CFS and CTL, and variables that changed significantly from test 1 (T1) to test 2 (T2) in ME/CFS with no change in CTL. Variables are presented for measures at peak exercise intensity and at the gas exchange or ventilatory/anaerobic threshold (VAT). Despite matching for aerobic capacity, the results from Keller et al.8 show persistent differences between 1) phenotypes-and 2) CPETs (T1 vs T2). In addition to changes in VO2 at peak and VAT, changes in these additional CPET measures should be considered when assessing ME/CFS baseline functional capacity (T1) and ability to reproduce T1 within normal variability during T2.
Table 1. CPET variables that differ between ME/CFS and low-active controls
| PEAK | VAT | |||
|---|---|---|---|---|
| T1 v T2 | CTL v ME/CFS | T1 v T2 | CTL v ME/CFS | |
| VO2 | X | X | # | |
| Ve | X | #(T2 only) | # | |
| VCO2 | X | # | # | |
| PetO2 | # | |||
| PetCO2 | X | |||
| OUES | # | |||
| OUESbsa | # | |||
| %predOUES | # | |||
| Ve/VCO2 slope | X | # | ||
| %predVO2peak | X | # | # | |
| HR | X | # | ||
| RPP | X | #(T2 only) | ||
| CTI | X | |||
| %predHRmax | X | |||
| %VO2peak@VAT | # | |||
| %predVO2peak@VAT | X | # | ||
| O2pulse | X | # | X | # |
| PP | # | |||
| Work (W) | X | # | # | |
| Time to level | X | # | # | |
| RER | #(T1 only) | |||
| RPE | #(T1 only ) | |||
| %Workpeak@VAT | Xac | #c | ||
| HR Recovery @ 2 min | #b | |||
X=difference between T1 and T2, #= difference between ME/CFS and CTL, a from Snell et al.55, b from Nelson et al.43, c from Lien et al.56
VO2 oxygen consumption, Ve minute ventilation, VCO2 carbon dioxide production, PETO2 pressure end tidal O2, PETCO2 pressure end tidal CO2, OUES oxygen uptake efficiency slope, OUESbsa OUES adjusted for body surface area, %predicted OUES actual OUES/predicted OUES, Ve/VCO2 slope of ventilatory equivalent of carbon dioxide, %predVO2peak actual VO2peak/predicted VO2peak, HR heart rate, RPP rate pressure product, CTI chronotropic index, %pred HRmax actual peak HR/(220-age), %peakVO2@VAT VO2@VAT/predicted VO2peak, O2pulse VO2 ml/min X heart rate, PP pulse pressure, Time to level time to peak or VAT level of exertion, RER respiratory exchange ratio, RPE rating of perceived exertion (6–20), %Workpeak@VAT Work@VAT/Work@peak
Minute ventilation (Ve)
At peak or maximum effort, a ubiquitous finding for ME/CFS is significantly compromised ventilatory function reported in a large single CPET study of ME/CFS57 and in numerous 2-d CPET studies8,9,14,43,55,56,58,59. Minute ventilation (Ve) is integral to the determination of VO2, and if compromised will reduce VO2. Effective mechanical ventilation creates the respiratory pump that is critical for sufficient pulmonary gas-exchange, blood flow distribution, systemic venous return to alter cardiac preload and afterload60, as well as lymphatic flow61 to, in part, remove metabolic waste. Factors should be considered that may impair ventilatory function in ME/CFS such as surgical scarring (e.g., C-section, breast reduction, abdominal or back procedures, etc.), injury that causes myofascial scarring and restriction or chronically shortened or tight musculature that can limit movement of fascia. Manipulative therapy or other approaches to relieve myofascial restrictions may help to limit maladaptive changes in the brain62 and periphery63,64 to pain, and possibly brainstem activity65. This neurodynamic approach should be considered to help regulate brainstem and autonomic function as well.
Blood pressure (BP)
Attenuated blood pressure responses during incremental exercise have been observed with some regularity in our clinic. A normal blood pressure response to incremental exercise includes an increase in systolic BP (SBP) of about 10 mmHg per 1 MET. Each 15-watt (W) workload increment is equivalent to 0.5 METs of energy expenditure. Therefore, if using a 15W/minute incremental protocol, SBP should increase about 10 mmHg every 30W of work, or every second minute (1 MET). Diastolic BP (DBP) should not vary during exercise more than ±10 mmHg from resting DBP32. If considering only resting and peak blood pressure, the kinetics of SBP during exercise is easily overlooked. Table 2 includes an example of attenuated SBP changes in a single patient during an incremental cycle ergometer CPET. In some individuals with ME/CFS this may be observed during T1 but is more often observed during T2 when ‘post-exertional’ following the first CPET. Applying this data to the energy demands of daily living for an individual, systolic pressure fails to increase during low to moderate work. From a practical perspective, when experiencing post-exertional malaise, a person with this blood pressure response is unable to increase SBP to provide sufficient blood with oxygen to muscles, brain, and organs during energy demands equivalent to normal daily activities. Orthostatic considerations are essential for one with this type of BP response. As most with ME/CFS will confirm, reading while reclined is preferable to improve comprehension. This is because reduced blood flow due to an attenuated SBP response during sitting or standing, decreases blood flow to the brain as well52–54,66–68.
Table 2. Blood pressure of a single ME/CFS patient during 2-d CPET
| CPET-1 | CPET-2 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Load watts (W) | HR bpm | RER | RPE 6-20 | SBP mmHg | DBP mmHg | Load watts (W) | HR bpm | RER | RPE 6-20 | SBP mmHg | DBP mmHg |
| Rest | 85 | 1.06 | 90 | 68 | Rest | 88 | 0.83 | 116 | 64 | ||
| 15 | 102 | 1.12 | 15 | 103 | 0.86 | ||||||
| 30 (~1 MET) | 96 | 0.82 | 9 | 100 | 68 | 30 (~1 MET) | 99 | 0.80 | 11 | 102 | 70 |
| 45 | 107 | 0.80 | 45 | 109 | 0.81 | ||||||
| 60 (2 METs) | 119 | 0.78 | 11 | 122 | 64 | 60 (2 METs) | 116 | 0.75 | 13 | 108 | 72 |
| 75 | 129 | 0.91 | 13 | 75 | 127 | 0.85 | |||||
| 90 (3 METs) | 141 | 0.96 | 15 | 138 | 66 | 90 (3 METs) | 144 | 0.99 | 17 | 126 | 70 |
| 105 | 151 | 1.08 | 17 | 105 | 152 | 1.06 | 18 | ||||
| 120 (4 METs) | 160 | 1.15 | 17 | 162 | 64 | 120 (4 METs) | 159 | 1.12 | 19 | 130 | 68 |
| 135 | 172 | 1.23 | 19 | 135 | 164 | 1.18 | 20 | ||||
| 150 (5 METs) | 174 | 1.26 | 19 | 160 | 64 | 150 (5 METs) | |||||
Rate pressure product (RPP) and pulse pressure (PP)
Rate pressure product is an indicator of heart work or myocardial oxygen consumption – the ability of the heart to use oxygen to pump blood effectively. A low RPP indicates an impaired ability of the heart to deliver oxygenated blood to muscles, brain, and organs for work. The product of HR and SBP, RPP during incremental exercise should increase to a value of approximately 25,000, although that value alone is not sufficient to determine if maximum effort was given69. There remains little information about the ‘boundaries’ of a normal RPP or implications for clinical outcomes. Still, RPP is highly relevant for ME/CFS as it relates directly to the ability of the heart to circulate blood. A failure to increase or a limited increase during incremental exercise implicates myocardial limitations due either to a low heart rate response (chronotropic incompetence) and/or an attenuated SBP response – both of which should be considered in the context of autonomic dysfunction when left ventricular function is normal. Likewise, pulse pressure (SBP-DBP) is inversely proportional to arterial compliance and should increase or ‘widen’ due to the increase in SBP during incremental exercise up to about 100 mmHg. A narrowed pulse pressure is evident in patients with postural orthostatic tachycardia syndrome (POTS), and for some can drop to 0 mmHg when standing70. Thus, it is a simple and important measure to assess in ME/CFS during exercise and recovery.
Ventilatory equivalent of carbon dioxide (Ve/VCO2)
The liters of ventilation needed to expire a liter of carbon dioxide is indicated by the ratio of Ve/VCO2 and is an indicator of ventilatory efficiency. The relationship is mostly linear although the slope of Ve/VCO2 may shift between rest and peak exercise. It is difficult to evaluate a real-time shift in the slope during a CPET, which would be ideal to assess the workload or heart rate at which there is a change in ventilatory efficiency. Therefore, the current recommendation to determine Ve/VCO2 slope is to include all data between rest and peak exercise. The higher the ratio, the more ventilation is required to eliminate CO2 indicating a lower ventilatory efficiency. Both methods of assessing Ve/VCO2 (ratio and slope) yield similar results although there may be less variability associated with the time at which the lowest Ve/VCO2 ratio occurs71. Impairment ratings associated with abnormally high Ve/VCO2 appear in Arena and Seitsema49. Since ventilatory function in ME/CFS is typically compromised, Ve/VCO2 should be routinely compared to normal values (generally < 30) to determine if it may be a factor in gas exchange dynamics to produce energy for work.
Chronotropic incompetence (CTI)
Also evident in Table 1 is the notably lower peak heart rate achieved during T2 despite meeting all other indicators of maximum effort required in our clinic (e.g., RER≥1.1, RPE≥17 out of 20). A patient who is unable to work to a heart rate that is at least 85% of age-predicted maximum heart rate or 80% of heart rate reserve may be limited by chronotropic incompetence. We have observed this during T1 but this phenomenon often emerges after the fatiguing stressor of T1 when the patient is post-exertional during T2. Chronotropic incompetence (CTI) is evidenced by an attenuated heart rate response that is not commensurate with the workload or metabolic demand. Brubaker and Kitzman discuss several ways to assess for CTI72. According to these authors, if maximum effort was evident by a respiratory exchange ratio (RER) ≥ 1.05, the more common method compares peak heart rate to 80-85% of age-predicted heart rate reserve (80-85% APHRR). However, occasionally a post-exertional ME/CFS patient is unable to achieve a RER of 1.05 despite reaching a rating of perceived exertion (RPE) ≥ 1773. In this case, the impact of PEM on patient effort during T2 should be considered before determining if CTI is present. With a submaximal effort, determination of CTI could utilize a calculation that considers both heart rate and workload74.
Heart rate recovery (HRR)
Recovery of heart rate soon after the cessation of exercise is a simple means to assess cardiac autonomic function. In some patient populations diagnosed with left ventricular dysfunction, an abnormally slow HR recovery (< -12 bpm in first minute)75 is typically associated with a poor prognosis76. HRR measured at 2 minutes following CPET uses a cut-off of 22 bpm which may be more predictive of survival77. A more complex assessment of the initial rate of decay or HR reduction following exercise (~60-90 sec) can signal reactivation of cardiac parasympathetic function, whereas the later ‘slow’ phase (4-5 min) of the decay curve may be related to cardiac sympathetic withdrawal78. A fast rate of vagal reactivation (initial phase) is common in endurance trained athletes. While there remains some debate as to the best method for assessing HRR, research to date indicates that HRR following CPET independently predicts mortality in patients with heart failure and coronary artery disease79. Evidence indicates that ME/CFS have altered regulation of cardiac autonomic function50, and a simple assessment of HRR following CPET provides one more perspective to evaluate the pathophysiology contributing to ME/CFS.
Work at ventilatory/anaerobic threshold (Work@VAT)
The ventilatory/anaerobic or gas exchange threshold (VAT) is the point during incremental exercise when energy production begins to shift increasingly from aerobic to anaerobic metabolism to meet an increasing rate of energy demand. It is possible for trained athletes to continue exercising above this threshold for a period of time, due largely to the ability to effectively clear and convert metabolic byproducts to usable sources of energy. Ultimately, however, work above VAT causes cumulative fatigue, and to continue exercising the intensity must decrease or work must stop.
As previously discussed, the intensity of work at VAT has been shown to be a critical level of energy production at/above that which provokes deleterious post-exertional responses and symptom exacerbation or PEM in those with ME/CFS55. The autonomic dysfunction prevalent in ME/CFS attenuates blood flow and therefore, the ability to effectively buffer anaerobiosis and clear fatigue-inducing anaerobic by-products. Consequently, VAT in ME/CFS occurs at an earlier or lower percentage of VO2peak. Pre-illness routine low-intensity tasks such as ADLs and IADLs may now exceed VAT, which is why even low-level tasks can provoke or exacerbate post-exertional symptoms. Learning to ‘live’ below the intensity that corresponds to Work@VAT is the most effective non-pharmacological strategy to avoid or attenuate the PEM response. For ME/CFS, Work@VAT measured during CPET is reported to decrease from T1 to T2, occurs at a lower workload (earlier onset) compared to CTL8,55,56, and is a predictor of PEM55. The heart rate that corresponds to Work@VAT (HR@VAT) is a simple way to monitor intensity of effort throughout the day to minimize the risk of a PEM response. With ME/CFS, averting PEM as best as possible, is the first step to improving functional capacity and tolerance for ADLs and IADLs.
Additional evidence to consider from CPET appear in Table 1. Again, to fully understand any potential impact on ME/CFS requires a comparison1) between T1 to T2, 2) with age/sex predicted normal values, and 3) to normal, expected responses during incremental exercise. As noted in the table, there are numerous variables that differed between T1 vs. T2 and/or ME/CFS and CTL at either peak effort and/or VAT.
Activity Management Strategies
Activity pacing
Pacing is an activity strategy that employs exertion and rest at intervals to reduce the risk of a PEM response. Unlike the typical pre-illness pattern of daily living in which sequential activities are completed throughout the day, pacing requires intervening recovery periods following each exertional demand. The typical pre-illness activity pattern could be described as ‘linear’ with one activity followed by another from rising in the morning until retiring at bedtime. In contrast, pacing requires a ‘circular’ activity pattern in which an exertion is followed by recovery before another exertion is attempted. For example, brushing teeth or shaving would be followed by recovery (lying down is the best recovery position to improve blood flow) before getting dressed for the day. The ACSM recommends a work (exertion) to rest (recovery) ratio of 1:3, where the duration of recovery is three times the duration of exertion, and recovery is a reduction in heart rate below HR@VAT and absence of symptoms32. Depending on the illness severity, this ratio may need to be modified to 1:4 or 1:6 for effective recovery. One who is attuned to her/his exertional limits can pace successfully to reduce the incidence of PEM. However, it is important to appreciate that PEM is provoked by physical, cognitive, and emotional stressors, or any combination thereof1. While CPET quantifies physical and physiological tolerances, the results of CPET do not account for the effects of cognitive or emotional stressors on the response of the limbic system.
Guidelines for and effectiveness of pacing require more evidence-based research in ME/CFS, but to date, activity pacing is the best strategy for successful activity management80,81. For many, an objective indicator is most helpful to redefine the new exertional limits imposed by ME/CFS. Mentioned previously, HR@VAT is simple to monitor. Additionally, using a device with a high/low alarm can provide audio biofeedback when HR@VAT is reached and recovery is necessary. Evidence indicates that many with ME/CFS routinely exceed HR@VAT during daily activities and provoke PEM15,38. At this time, objective HR biofeedback is the most effective strategy to help regulate exertion and guide recovery throughout the day to reduce or avert PEM.
Activity journal
Symptoms of ME/CFS and PEM are often cyclic, so pacing requires a fluid approach to exercise that can be adjusted as symptoms dictate with a goal to avoid PEM. Since PEM is a delayed response to exertion that may occur in subsequent hours or days, documenting the exercise time of day and FITT parameters discussed earlier, is critical to correlate the exertional stressor with a PEM response. Keeping a simple journal, including feelings/sensations during or immediately after physical exertion or any cognitive or emotional stressor, provides the ‘look back’ to assess if/how the exercise sessions or stress-inducing event provoked PEM and should be modified going forward. Ultimately, however, the presence or absence of PEM in the hours or days following exercise must always guide the progression of an exercise program. Modification of an exercise session– or any exertional stressors, to minimize the risk of a PEM response is essential to stabilize and avoid worsening the functional status.
Orthostatic considerations
The deleterious impact of ME/CFS on physical and physiological function leads to an overall reduction of functional capacity. A major factor due to the pathophysiology of ME/CFS is impaired blood flow to muscles, brain, and organs. Some non-pharmacological strategies to improve blood flow are easy to employ. These include but are not limited to: wearing sport-grade compression garments82, exercising in water up to the shoulders/neck, exercising in supine/prone postures to minimize the challenge of gravity on blood distribution, rhythmic gripping of fists or crossing of legs when standing to employ the pressor response mechanism, and/or volume loading with a combination of water and low-sugar electrolyte beverages.
As ME/CFS forces a more low-active lifestyle, the decline in upright activities can reduce engagement of core stability muscles to maintain correct spinal alignment. Effective blood flow83–85 and movement of lymph86,87 are compromised with deterioration of spinal alignment. Practicing core stability exercises while prone/supine is helpful to maintain healthful spinal alignment if done within the limits of exercise tolerance explained above. In addition, body work to release tight muscles and restricted fascia that can result with a low-active lifestyle also assists to improve movement of blood and lymph. Our clinic provides 30 minutes of fascial release-type work immediately after the 2-d CPET. Patients report that this type of work improves their symptom complex, particularly their ability to ventilate more effectively with release work around the shoulders/neck and other areas of pain or restriction. Additional strategies to potentially mitigate symptoms of ME/CFS are discussed in Keller et al.8.
Conclusion
Over time, those with ME/CFS downregulate daily activity level due to profound fatigue, cognitive impairment or ‘brain fog’, pain, PEM, and other symptoms. Compared to inactive and otherwise healthy counterparts, people with ME/CFS spend more time each day in sedentary behaviors versus moderate and vigorous activities to avert symptom exacerbation or PEM. However, it is clear that many with ME/CFS maintain activity levels that exceed their metabolic limitations and consequently experience PEM symptoms with regularity. With many physical, emotional, and cognitive stressors of daily life exceeding metabolic limitations, it is evident that those with ME/CFS can experience PEM even during a physically low-active day.
The complex multi-symptom disease of ME/CFS, at first glance, appears to encompass many and disparate symptoms making diagnosis and treatment uniquely challenging. Without an established biomarker88, consistent prodromal event, or a cure, managing ME/CFS to minimize both the loss of function and the hallmark PEM experience is a medical riddle and typically focuses on symptom management. Closer examination of CPET results provides perhaps a view of the ‘final common pathway’ of energy production for a system that is challenged in ways we don’t fully understand. The commonality of CPET results for those with ME/CFS suggests that practitioners should focus on the underlying process(es) or mechanism(s) as much or more than on symptoms alone. Strategies to address autonomic dysfunction and improve ventilatory function and flow of blood and lymph throughout the body, and to relieve potential fascial constraints of the brainstem/neck/shoulder areas may begin to help mitigate the foundational underpinnings of disrupted energy metabolism in people with ME/CFS.
Declarations
- Conflicts of Interest Statement
- The authors conduct cardiopulmonary exercise testing for a fee at the non-profit PaceForward Foundation in Ithaca, NY, USA, to help inform diagnosis and disease management, and provide objective evidence of functional capacity.
- Acknowledgements
- Our appreciation to the hundreds of people with ME/CFS tested at Ithaca College and the PaceForward Foundation whose personal insights and CPET data provided the groundwork for the clinical reasoning that guides our work today.
References
- IOM (Institute of Medicine). Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness. National Academies Press; 2015.
- Carruthers BM, Jain AK, De Meirleir KL, et al. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Clinical Working Case Definition, Diagnostic and Treatment Protocols. Journal Of Chronic Fatigue Syndrome. 2003;11(1):7-115. doi:10.1300/J092v11n01_02
- Stussman B, Williams A, Snow J, et al. Characterization of Post–exertional Malaise in Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Front Neurol. 2020;11. doi:10.3389/fneur.2020.01025
- Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med. 1994;121(12):953-959. doi:10.7326/0003-4819-121-12-199412150-00009
- Holtzman CS, Bhatia S, Cotler J, Jason LA. Assessment of Post-Exertional Malaise (PEM) in Patients with Myalgic Encephalomyelitis (ME) and Chronic Fatigue Syndrome (CFS): A Patient-Driven Survey. Diagnostics (Basel). 2019;9(1):26. doi:10.3390/diagnostics9010026
- Chu L, Valencia IJ, Garvert DW, Montoya JG. Deconstructing post-exertional malaise in myalgic encephalomyelitis/ chronic fatigue syndrome: A patient-centered, cross-sectional survey. PLOS ONE. 2018;13(6):e0197811. doi:10.1371/journal.pone.0197811
- Cotler J, Holtzman C, Dudun C, Jason LA. A Brief Questionnaire to Assess Post-Exertional Malaise. Diagnostics (Basel). 2018;8(3):66. doi:10.3390/diagnostics8030066
- Keller B, Receno CN, Franconi CJ, et al. Cardiopulmonary and metabolic responses during a 2-day CPET in myalgic encephalomyelitis/chronic fatigue syndrome: translating reduced oxygen consumption to impairment status to treatment considerations. J Transl Med. 2024;22(1):627. doi:10.1186/s12967-024-05410-5
- Keller BA, Pryor JL, Giloteaux L. Inability of myalgic encephalomyelitis/chronic fatigue syndrome patients to reproduce VO2peak indicates functional impairment. Journal of Translational Medicine. 2014;12(1):104. doi:10.1186/1479-5876-12-104
- Paul L, Wood L, Behan WMH, Maclaren WM. Demonstration of delayed recovery from fatiguing exercise in chronic fatigue syndrome. European Journal of Neurology. 1999;6(1):63-69. doi:10.1046/j.1468-1331.1999.610063.x
- van Campen C (Linda) MC, Rowe PC, Visser FC. Deconditioning does not explain orthostatic intolerance in ME/CFS (myalgic encephalomyelitis/chronic fatigue syndrome). Journal of Translational Medicine. 2021;19(1):193. doi:10.1186/s12967-021-02819-0
- VanNess JM, Stevens SR, Bateman L, Stiles TL, Snell CR. Postexertional malaise in women with chronic fatigue syndrome. J Womens Health (Larchmt). 2010;19(2):239-244. doi:10.1089/jwh.2009.1507
- Lim EJ, Kang EB, Jang ES, Son CG. The Prospects of the Two-Day Cardiopulmonary Exercise Test (CPET) in ME/CFS Patients: A Meta-Analysis. Journal of Clinical Medicine. 2020;9(12):12. doi:10.3390/jcm9124040
- Vermeulen RC, Kurk RM, Visser FC, Sluiter W, Scholte HR. Patients with chronic fatigue syndrome performed worse than controls in a controlled repeated exercise study despite a normal oxidative phosphorylation capacity. J Transl Med. 2010;8(1):93. doi:10.1186/1479-5876-8-93
- Moore GE, Keller BA, Stevens J, et al. Recovery from Exercise in Persons with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). Medicina. 2023;59(3):3. doi:10.3390/medicina59030571
- Aerenhouts D, Ickmans K, Clarys P, et al. Sleep characteristics, exercise capacity and physical activity in patients with chronic fatigue syndrome. Disabil Rehabil. 2015;37(22):2044-2050. doi:10.3109/09638288.2014.993093
- Black CD, O’Connor PJ, McCully KK. Increased daily physical activity and fatigue symptoms in chronic fatigue syndrome. Dyn Med. 2005;4:3. doi:10.1186/1476-5918-4-3
- van Campen C (Linda) MC, Rowe PC, Visser FC. Validation of the Severity of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome by Other Measures than History: Activity Bracelet, Cardiopulmonary Exercise Testing and a Validated Activity Questionnaire: SF-36. Healthcare. 2020;8(3):3. doi:10.3390/healthcare8030273
- Kop WJ, Lyden A, Berlin AA, et al. Ambulatory monitoring of physical activity and symptoms in fibromyalgia and chronic fatigue syndrome. Arthritis & Rheumatism. 2005;52(1):296-303. doi:10.1002/art.20779
- Tryon WW, Jason L, Frankenberry E, Torres-Harding S. Chronic fatigue syndrome impairs circadian rhythm of activity level. Physiology & Behavior. 2004;82(5):849-853. doi:10.1016/j.physbeh.2004.07.005
- van der Werf SP, Prins JB, Vercoulen JHMM, van der Meer JWM, Bleijenberg G. Identifying physical activity patterns in chronic fatigue syndrome using actigraphic assessment. Journal of Psychosomatic Research. 2000;49(5):373-379. doi:10.1016/S0022-3999(00)00197-5
- Rekeland IG, Sørland K, Bruland O, et al. Activity monitoring and patient-reported outcome measures in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome patients. PLOS ONE. 2022;17(9):e0274472. doi:10.1371/journal.pone.0274472
- Receno CN, Harenberg S, Stevens J, Stevens SR, Keller B. Physical activity levels in myalgic encephalomyelitis/chronic fatigue syndrome before and after a 2-day cardiopulmonary exercise test protocol. Fatigue: Biomedicine, Health & Behavior. 2026;14(2):131-143. doi:10.1080/21641846.2026.2620357
- Compendium of Physical Activities. Accessed September 11, 2026. https://sites.google.com/site/compendiumofphysicalactivities/Home
- Bains W. Treating Chronic Fatigue states as a disease of the regulation of energy metabolism. Medical Hypotheses. 2008;71(4):481-488. doi:10.1016/j.mehy.2008.02.022
- Brown AE, Jones DE, Walker M, Newton JL. Abnormalities of AMPK Activation and Glucose Uptake in Cultured Skeletal Muscle Cells from Individuals with Chronic Fatigue Syndrome. PLOS ONE. 2015;10(4):e0122982. doi:10.1371/journal.pone.0122982
- Fulle S, Mecocci P, Fanó G, et al. Specific oxidative alterations in vastus lateralis muscle of patients with the diagnosis of chronic fatigue syndrome. Free Radical Biology and Medicine. 2000;29(12):1252-1259. doi:10.1016/S0891-5849(00)00419-6
- Van Campen C (Linda) MC, Rowe PC, Visser FC. Validity of 2-Day Cardiopulmonary Exercise Testing in Male Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. APE. 2020;10(01):68-80. doi:10.4236/ape.2020.101007
- Fulcher K, White P. Strength and physiological response to exercise in patients with chronic fatigue syndrome. J Neurol Neurosurg Psychiatry. 2000;69(3):302-307. doi:10.1136/jnnp.69.3.302
- Vermeulen RC, Vermeulen van Eck IW. Decreased oxygen extraction during cardiopulmonary exercise test in patients with chronic fatigue syndrome. J Transl Med. 2014;12(1):20. doi:10.1186/1479-5876-12-20
- Populations B on the H of S, Syndrome C on the DC for MEF. Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness. National Academies Press; 2015.
- Ozemek C, Bonikowske A, Christle J, Gallo P. ACSM’s Guidelines for Exercise Testing and Prescription. Lippincott Williams & Wilkins; 2025.
- George SZ, Wittmer VT, Fillingim RB, Robinson ME. Comparison of Graded Exercise and Graded Exposure Clinical Outcomes for Patients With Chronic Low Back Pain. Journal of Orthopaedic & Sports Physical Therapy. 2010;40(11):694-704. doi:10.2519/jospt.2010.3396
- Poort H, Peters MEWJ, van der Graaf WTA, et al. Cognitive behavioral therapy or graded exercise therapy compared with usual care for severe fatigue in patients with advanced cancer during treatment: a randomized controlled trial. Annals of Oncology. 2020;31(1):115-122. doi:10.1016/j.annonc.2019.09.002
- Burge AT, Gadowski AM, Romero L, et al. The effect of graded exercise therapy on fatigue in people with serious respiratory illness: a systematic review. Eur Respir Rev. 2024;33(174):240027. doi:10.1183/16000617.0027-2024
- Vink M, Vink-Niese A. Graded exercise therapy for myalgic encephalomyelitis/chronic fatigue syndrome is not effective and unsafe. Re-analysis of a Cochrane review. Health Psychology Open. 2018;5(2):2055102918805187. doi:10.1177/2055102918805187
- Overview | Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management | Guidance | NICE. October 29, 2021. Accessed September 6, 2025. https://www.nice.org.uk/guidance/ng206
- Clague-Baker N, Tyson S, Leslie K, Dawes H, Bull M, Hilliard N. Home-based testing protocol to measure physiological responses to everyday activities in ME: a feasibility study. Fatigue: Biomedicine, Health & Behavior. 2023;11(2-4):142-156. doi:10.1080/21641846.2023.2245584
- Larun L, Brurberg KG, Odgaard-Jensen J, Price JR. Exercise therapy for chronic fatigue syndrome - Larun, L - 2024 | Cochrane Library. Accessed September 11, 2026. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003200.pub9/full
- Zhao L, Gou B, Zhang M. The efficacy of exercise in patients with myalgic encephalomyelitis/chronic fatigue syndrome: A systematic review and meta-analysis. Journal of Psychosomatic Research. 2026;207:112677. doi:10.1016/j.jpsychores.2026.112677
- Schultz MG, La Gerche A, Sharman JE. Blood Pressure Response to Exercise and Cardiovascular Disease. Curr Hypertens Rep. 2017;19(11):89. doi:10.1007/s11906-017-0787-1
- Barron A, Dhutia N, Mayet J, Hughes AD, Francis DP, Wensel R. Test–retest repeatability of cardiopulmonary exercise test variables in patients with cardiac or respiratory disease. Eur J Prev Cardiolog. 2014;21(4):445-453. doi:10.1177/2047487313518474
- Nelson MJ, Buckley JD, Thomson RL, Clark D, Kwiatek R, Davison K. Diagnostic sensitivity of 2-day cardiopulmonary exercise testing in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Journal of Translational Medicine. 2019;17(1):80. doi:10.1186/s12967-019-1836-0
- Davenport TE, Stevens SR, Stevens J, Snell CR, Van Ness JM. Properties of measurements obtained during cardiopulmonary exercise testing in individuals with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. WORK. 2020;66(2):247-256. doi:10.3233/WOR-203170
- Weltman A, Snead D, Stein P, et al. Reliability and Validity of a Continuous Incremental Treadmill Protocol for the Determination of Lactate Threshold, Fixed Blood Lactate Concentrations, and V̇O2max. Int J Sports Med. 1990;11(1):26-32. doi:10.1055/s-2007-1024757
- Aunola S, Rusko H. Reproducibility of aerobic and anaerobic thresholds in 20–50 year old men. Europ J Appl Physiol. 1984;53(3):260-266. doi:10.1007/BF00776600
- Larson, B, et al. Reproducibility of Measurements Obtained During... : Cardiopulmonary Physical Therapy Journal. Ovid. doi:10.1097/CPT.0000000000000100
- Stevens S, Snell C, Stevens J, Keller B, VanNess JM. Cardiopulmonary Exercise Test Methodology for Assessing Exertion Intolerance in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Front Pediatr. 2018;6. doi:10.3389/fped.2018.00242
- Arena, R, KE Seitsema. Cardiopulmonary Exercise Testing in the Clinical Evaluation of Patients With Heart and Lung Disease | Circulation. Accessed September 11, 2026. https://www.ahajournals.org/doi/full/10.1161/CIRCULATIONAHA.109.914788
- Nelson MJ, Bahl JS, Buckley JD, Thomson RL, Davison K. Evidence of altered cardiac autonomic regulation in myalgic encephalomyelitis/chronic fatigue syndrome. Medicine (Baltimore). 2019;98(43):e17600. doi:10.1097/MD.0000000000017600
- Wirth K, Scheibenbogen C. A Unifying Hypothesis of the Pathophysiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Recognitions from the finding of autoantibodies against ß2-adrenergic receptors. Autoimmunity Reviews. 2020;19(6):102527. doi:10.1016/j.autrev.2020.102527
- van Campen C (Linda) MC, Verheugt FWA, Rowe PC, Visser FC. Cerebral blood flow is reduced in ME/CFS during head-up tilt testing even in the absence of hypotension or tachycardia: A quantitative, controlled study using Doppler echography. Clinical Neurophysiology Practice. 2020;5:50-58. doi:10.1016/j.cnp.2020.01.003
- van Campen C (Linda) MC, Verheugt FWA, Rowe PC, Visser FC. Orthostatic chronotropic incompetence in patients with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). IBRO Neuroscience Reports. 2023;15:1-10. doi:10.1016/j.ibneur.2023.04.005
- van Campen C (Linda) MC, Verheugt FWA, Rowe PC, Visser FC. The Cardiac Output–Cerebral Blood Flow Relationship Is Abnormal in Most Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients with a Normal Heart Rate and Blood Pressure Response During a Tilt Test. Healthcare. 2024;12(24):2566. doi:10.3390/healthcare12242566
- Snell CR, Stevens SR, Davenport TE, Van Ness JM. Discriminative Validity of Metabolic and Workload Measurements for Identifying People With Chronic Fatigue Syndrome. Phys Ther. 2013;93(11):1484-1492. doi:10.2522/ptj.20110368
- Lien K, Johansen B, Veierød MB, et al. Abnormal blood lactate accumulation during repeated exercise testing in myalgic encephalomyelitis/chronic fatigue syndrome. Physiological Reports. 2019;7(11):e14138. doi:10.14814/phy2.14138
- Cook DB, VanRiper S, Dougherty RJ, et al. Cardiopulmonary, metabolic, and perceptual responses during exercise in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): A Multi-site Clinical Assessment of ME/CFS (MCAM) sub-study. PLOS ONE. 2022;17(3):e0265315. doi:10.1371/journal.pone.0265315
- VanNess, J. Mark, et al. Postexertional Malaise in Women with Chronic Fatigue Syndrome. 2010. Accessed September 11, 2026. https://journals.sagepub.com/doi/abs/10.1089/jwh.2009.1507
- van Campen C (Linda) MC, Rowe PC, Visser FC. Two-Day Cardiopulmonary Exercise Testing in Females with a Severe Grade of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Comparison with Patients with Mild and Moderate Disease. Healthcare. 2020;8(3):192. doi:10.3390/healthcare8030192
- Pinsky MR. The effects of mechanical ventilation on the cardiovascular system. Crit Care Clin. 1990;6(3):663-678.
- Thorup L, Dehn AM, Heiberg J, et al. Reduced Lymphatic Activity During Positive Pressure Ventilation and General Anesthesia—A Cause of Postoperative Edema? Acta Anaesthesiol Scand. 2025;69(6):e70066. doi:10.1111/aas.70066
- Niddam DM, Lee SH, Su YT, Chan RC. Brain structural changes in patients with chronic myofascial pain. Eur J Pain. 2017;21(1):148-158. doi:10.1002/ejp.911
- Lewit K, Olsanska S. Clinical Importance of Active Scars: Abnormal Scars as a Cause of Myofascial Pain. Journal of Manipulative and Physiological Therapeutics. 2004;27(6):399-402. doi:10.1016/j.jmpt.2004.05.004
- Rowe PC, Fontaine KR, Lauver M, et al. Neuromuscular Strain Increases Symptom Intensity in Chronic Fatigue Syndrome. PLOS ONE. 2016;11(7):e0159386. doi:10.1371/journal.pone.0159386
- Ghorbanpour A, Shadmehr A, Talebian Moghaddam S, Hadian Rasanani M. The possibility of changes of brain activity following myofascial release in patients with nonspecific chronic low back pain: A hypothesis. Medical Hypotheses. 2023;176:111082. doi:10.1016/j.mehy.2023.111082
- Christopoulos EM, Tantanis D, Huang K, et al. Mapping cerebral blood flow in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and orthostatic intolerance: insights from a systematic review. J Transl Med. 2025;23(1):963. doi:10.1186/s12967-025-06954-w
- Li X, Julin P, Li TQ. Limbic Perfusion Is Reduced in Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). Tomography. 2021;7(4):675-687. doi:10.3390/tomography7040056
- van Campen C (Linda) MC, Rowe PC, Visser FC. Worsening Symptoms Is Associated with Larger Cerebral Blood Flow Abnormalities during Tilt-Testing in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). Medicina. 2023;59(12):2153. doi:10.3390/medicina59122153
- Pinkstaff S, Peberdy MA, Kontos MC, Finucane S, Arena R. Quantifying Exertion Level During Exercise Stress Testing Using Percentage of Age-Predicted Maximal Heart Rate, Rate Pressure Product, and Perceived Exertion. Mayo Clinic Proceedings. 2010;85(12):1095-1100. doi:10.4065/mcp.2010.0357
- Homan TD, Bordes SJ, Cichowski E. Physiology, Pulse Pressure. In: StatPearls. StatPearls Publishing; 2026. Accessed September 3, 2026. http://www.ncbi.nlm.nih.gov/books/NBK482408/
- Sietsema, KE, Sue, DY, Stringer, WW, S Ward. Wasserman & Whipp’s Principles of Exercise Testing and Interpretation: Including Pathophysiology and Clinical Applications. 6th ed. LWW; 2020.
- Brubaker, PH, Kitzman, DW. Chronotropic Incompetence | Circulation. Circulation. 2011;123. Accessed September 11, 2026. https://www.ahajournals.org/doi/full/10.1161/CIRCULATIONAHA.110.940577
- Borg G. Perceived exertion as an indicator of somatic stress. Journal of Rehabilitation Medicine. 1970;2(2):92-98. doi:10.2340/1650197719702239298
- Wilkoff BL, Miller RE. Exercise Testing for Chronotropic Assessment. Cardiology Clinics. 1992;10(4):705-717. doi:10.1016/S0733-8651(18)30211-X
- Cole CR, Blackstone EH, Pashkow FJ, Snader CE, Lauer MS. Heart-Rate Recovery Immediately after Exercise as a Predictor of Mortality. New England Journal of Medicine. 1999;341(18):1351-1357. doi:10.1056/NEJM199910283411804
- Watanabe J, Thamilarasan M, Blackstone EH, Thomas JD, Lauer MS. Heart Rate Recovery Immediately After Treadmill Exercise and Left Ventricular Systolic Dysfunction as Predictors of Mortality: The Case of Stress Echocardiography. Circulation. 2001;104(16):1911-1916. doi:10.1161/circ.104.16.1911
- Lipinski MJ, Vetrovec GW, Froelicher VF. Importance of the first two minutes of heart rate recovery after exercise treadmill testing in predicting mortality and the presence of coronary artery disease in men. The American Journal of Cardiology. 2004;93(4):445-449. doi:10.1016/j.amjcard.2003.10.039
- Peçanha T, Silva-Júnior ND, Forjaz CL de M. Heart rate recovery: autonomic determinants, methods of assessment and association with mortality and cardiovascular diseases. Clinical Physiology and Functional Imaging. 2014;34(5):327-339. doi:10.1111/cpf.12102
- Dewar A, Kass L, Stephens RCM, Tetlow N, Desai T. Heart Rate Recovery Assessed by Cardiopulmonary Exercise Testing in Patients with Cardiovascular Disease: Relationship with Prognosis. International Journal of Environmental Research and Public Health. 2023;20(6):4678. doi:10.3390/ijerph20064678
- Clague-Baker N, Davenport TE, Wickens B, et al. Pacing with a heart rate monitor for people with myalgic encephalomyelitis/chronic fatigue syndrome and long COVID: a feasibility study. Fatigue: Biomedicine, Health & Behavior. 2026;14(1):74-96. doi:10.1080/21641846.2025.2565103
- Clague-Baker N, Davenport TE, Madi M, et al. An international survey of experiences and attitudes towards pacing using a heart rate monitor for people with myalgic encephalomyelitis/chronic fatigue syndrome. WORK. 2023;74(4):1225-1234. doi:10.3233/WOR-220512
- van Campen C (Linda) MC, Rowe PC, Visser FC. Compression Stockings Improve Cardiac Output and Cerebral Blood Flow during Tilt Testing in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Patients: A Randomized Crossover Trial. Medicina. 2022;58(1):51. doi:10.3390/medicina58010051
- Kim Y, Cha Y, Yoon S. Effects of hip extensor exercises on neck disability, cervical alignment, muscle imbalance, and blood flow in forward head posture. Technology and Health Care. 2026;34(2):145-153. doi:10.1177/09287329251392400
- Navalta, JW, Hrncir, SP. CORE STABILIZATION EXERCISES ENHANCE LACTATE... : Journal of Strength and Conditioning Research. Ovid. Accessed September 11, 2026. https://www.ovid.com/jnls/nsca-jscr/fulltext/00124278-200711000-00057~core-stabilization-exercises-enhance-lactate-clearance
- Paungmali A, Henry LJ, Sitilertpisan P, Pirunsan U, Uthaikhup S. Improvements in tissue blood flow and lumbopelvic stability after lumbopelvic core stabilization training in patients with chronic non-specific low back pain. Journal of Physical Therapy Science. 2016;28(2):635-640. doi:10.1589/jpts.28.635
- Solari E, Marcozzi C, Negrini D, Moriondo A. Lymphatic Vessels and Their Surroundings: How Local Physical Factors Affect Lymph Flow. Biology. 2020;9(12):463. doi:10.3390/biology9120463
- Hou Y, Wu J, Yang S, et al. The spinal lymphatic system: an emerging pathway bridging fluid homeostasis, immunity, and disease. Bone Res. 2026;14(1):28. doi:10.1038/s41413-026-00508-6
- Beentjes SV, Miralles Méharon A, Kaczmarczyk J, et al. Replicated blood-based biomarkers for myalgic encephalomyelitis not explicable by inactivity. EMBO Mol Med. 2025;17(7):15. doi:10.1038/s44321-025-00258-8
Article information
Authors
- Candace N. RecenoDepartment of Exercise Science and Athletic Training, Ithaca College, Ithaca, NY; The PaceForward Foundation, Ithaca, NYCorresponding author · [email protected]
- Betsy A. KellerThe PaceForward Foundation, Ithaca, NY
How to cite
Receno, C. N., Keller, B. A., 2026. Clinical Knowledge and Reasoning Informed by Cardiopulmonary Exercise Testing to Guide Physical Activity and Management of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Medical Research Archives, [online] 14(10). https://doi.org/10.18103/mra.2026.0719
Record
- Journal
- Medical Research Archives
- Issue
- Vol 14 No 10 (2026)
- Section
- Review Articles
- Published
- 31 October 2026
- ISSN
- 2375-1924
- Downloads
- 146
Copyright and licence
Published by the European Society of Medicine under a Creative Commons Attribution 4.0 International licence (CC BY 4.0), which permits unrestricted use, distribution and reproduction in any medium, provided the original authors and source are credited.